MSC-1186, a Highly Selective Pan-SRPK Inhibitor Based on an Exceptionally Decorated Benzimidazole-Pyrimidine Core-Reference-Cited by-同舟云学术

MSC-1186, a Highly Selective Pan-SRPK Inhibitor Based on an Exceptionally Decorated Benzimidazole-Pyrimidine Core

Published:2022-12-14 Issue:1 Volume:66 Page:837-854
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Schröder Martin¹²^ORCID,Leiendecker Matthias³,Grädler Ulrich³,Braun Juliane³,Blum Andreas³^ORCID,Wanior Marek¹,Berger Benedict-Tilman¹²^ORCID,Krämer Andreas¹²,Müller Susanne¹²,Esdar Christina³,Knapp Stefan¹²^ORCID,Heinrich Timo³^ORCID

Affiliation:

1. SGC Frankfurt, Goethe University Frankfurt, Buchmann Institute for Life Sciences (BMLS), Riedberg Campus, Max-von-Laue-Str. 15, 60438 Frankfurt am Main, Germany

2. Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, Riedberg Campus, Max-von-Laue-Str. 9, 60438 Frankfurt am Main, Germany

3. Merck Healthcare KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.2c01705

Reference53 articles.

1. Protein kinases — the major drug targets of the twenty-first century?

2. Kinase drug discovery 20 years after imatinib: progress and future directions

3. Trends in kinase drug discovery: targets, indications and inhibitor design

4. The safety of JAK kinase inhibitors for the treatment of myelofibrosis

5. The art of the chemical probe

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantum chemical package Jaguar: A survey of recent developments and unique features;The Journal of Chemical Physics;2024-08-02

2. Mesoporous CuMn2O4 nanoframework as an efficient catalyst for the synthesis of benzimidazole derivatives through air oxidative coupling in water;Molecular Catalysis;2024-05

3. Serine-arginine protein kinases and their targets in viral infection and their inhibition;Cellular and Molecular Life Sciences;2023-05-17

4. SRPKs: a promising therapeutic target in cancer;Clinical and Experimental Medicine;2023-04-07